Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC için istatistikler

Toplam ziyaret

views
Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC 0

Aylık toplam ziyaret

views
Ekim 2024 0
Kasım 2024 0
Aralık 2024 0
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0